Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5076101
Max Phase: Preclinical
Molecular Formula: C24H32FN5O2
Molecular Weight: 441.55
Molecule Type: Unknown
Associated Items:
ID: ALA5076101
Max Phase: Preclinical
Molecular Formula: C24H32FN5O2
Molecular Weight: 441.55
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCc1cc(O)c(F)cc1-c1cc(N[C@@H](C)CO)c2nc(NCCCN(C)C)ncc2c1
Standard InChI: InChI=1S/C24H32FN5O2/c1-5-16-11-22(32)20(25)12-19(16)17-9-18-13-27-24(26-7-6-8-30(3)4)29-23(18)21(10-17)28-15(2)14-31/h9-13,15,28,31-32H,5-8,14H2,1-4H3,(H,26,27,29)/t15-/m0/s1
Standard InChI Key: WAUZCJHXYOESCD-HNNXBMFYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.55 | Molecular Weight (Monoisotopic): 441.2540 | AlogP: 3.86 | #Rotatable Bonds: 10 |
Polar Surface Area: 93.54 | Molecular Species: BASE | HBA: 7 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.38 | CX Basic pKa: 9.44 | CX LogP: 2.25 | CX LogD: 1.43 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.36 | Np Likeness Score: -0.64 |
1. Wellaway CR, Baldwin IR, Bamborough P, Barker D, Bartholomew MA, Chung CW, Dümpelfeld B, Evans JP, Fazakerley NJ, Homes P, Keeling SP, Lewell XQ, McNab FW, Morley J, Needham D, Neu M, van Oosterhout AJM, Pal A, Reinhard FBM, Rianjongdee F, Robertson CM, Rowland P, Shah RR, Sherriff EB, Sloan LA, Teague S, Thomas DA, Wellaway N, Wojno-Picon J, Woolven JM, Coe DM.. (2022) Investigation of Janus Kinase (JAK) Inhibitors for Lung Delivery and the Importance of Aldehyde Oxidase Metabolism., 65 (1.0): [PMID:34928601] [10.1021/acs.jmedchem.1c01765] |
Source(1):